AbbVie Total Long Term Liabilities 2012-2026 | ABBV

AbbVie total long term liabilities for the quarter ending March 31, 2026 were $97.106B, a 2.99% increase year-over-year.

  • AbbVie total long term liabilities for 2024 were $93.048B, a 7.6% increase from 2023.
  • AbbVie total long term liabilities for 2023 were $86.473B, a 5.99% decline from 2022.
  • AbbVie total long term liabilities for 2022 were $91.98B, a 4.09% decline from 2021.

AbbVie Total Long Term Liabilities 2012-2026 | ABBV

  • AbbVie total long term liabilities for 2024 were $93.048B, a 7.6% increase from 2023.
  • AbbVie total long term liabilities for 2023 were $86.473B, a 5.99% decline from 2022.
  • AbbVie total long term liabilities for 2022 were $91.98B, a 4.09% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B